Tuesday 19 February 2019

Back in Versarien, but as usual my timing sucks

Today saw a rare convergence of two targets.

I've been waiting for SBTX:SkinBioTherapeutics to hit 20p bid price in order to sell my SIPP holding. After missing out on 19.75p on Friday I thought my chance had gone, but this morning it came back and the limit sell order triggered, selling for 20.11p making a profit of £496.16 (49%) and liberating £1,496.10.

At exactly the same time, VRS:Versarien dipped bellow 100p, which has always been my target to buy back in. I really thought I had missed the chance, as resistance seemed to be at around 124p and it never got near my target. As soon as it went below 100p I bought some, convinced it was about to head north again as others like myself spotted a good deal.

I bought 1,505 shares at 98.85p costing £1,499.64. There was much celebrating, until close of business when the price had plummeted to a purchase price of 86p. So I managed a 15% loss of £232 on day one!

Never mind eh.

I'm just really happy to be back in VRS:Versarien as I didn't really want to sell. With hindsight I'm glad I did, as I made £4,000 profit in a very short period of time. There's a hell of a lot going on with them, and they have so many divisions developing the next most important tech that we're likely to see. They are doing it with global players, which takes time. They may decline further, which will be annoying, but from reading the bulletin boards it's clear there is active shorting and a concerted attack on the share price. That won't last.

I waited 3 years for OPTI:Optibiotix to become profitable for me. I'm very happy to wait as long for VRS:Versarien, and if they can stay this low for another month I'll have £2,000 from my pension transfer to add some more.

Meanwhile the portfolio is up by £1,544 on the week so far, despite cashing in £500 paper profit from the sale today, with OPTI:Optibiotix and CEY:Centamin being the main risers.

I really can't express just how happy I am to be back in VRS:Versarien, especially coming just a week after getting back into CWR:Ceres Power, another of my favourites. I've been watching for a long time yearning to be able to call myself a shareholder in both.

No comments:

Post a Comment